Datasheet

MSDS-No.: 175676
V007.0
X32-10i LIQUID FLUX
Page 8 of 12
Acute dermal toxicity:
Hazardous components
CAS-No.
Value
type
Value
Route of
application
Exposure
time
Species
Method
Propan-2-ol
67-63-0
LD50
12.870 mg/kg
dermal
rabbit
Biphenyl-2-ol
90-43-7
LD50
> 5.000 mg/kg
dermal
rabbit
Skin corrosion/irritation:
Hazardous components
CAS-No.
Result
Exposure
time
Species
Method
Propan-2-ol
67-63-0
slightly irritating
4 h
rabbit
OECD Guideline 404 (Acute
Dermal Irritation / Corrosion)
Adipic acid
124-04-9
slightly irritating
rabbit
Biphenyl-2-ol
90-43-7
irritating
4 h
rabbit
OECD Guideline 404 (Acute
Dermal Irritation / Corrosion)
Serious eye damage/irritation:
Hazardous components
CAS-No.
Result
Exposure
time
Species
Method
Propan-2-ol
67-63-0
moderately irritating
rabbit
OECD Guideline 405 (Acute
Eye Irritation / Corrosion)
Adipic acid
124-04-9
moderately irritating
rabbit
Biphenyl-2-ol
90-43-7
irritating
rabbit
OECD Guideline 405 (Acute
Eye Irritation / Corrosion)
Respiratory or skin sensitization:
Hazardous components
CAS-No.
Result
Test type
Species
Method
Propan-2-ol
67-63-0
not sensitising
Buehler
test
guinea pig
OECD Guideline 406 (Skin
Sensitisation)
Adipic acid
124-04-9
not sensitising
guinea pig
Biphenyl-2-ol
90-43-7
not sensitising
Guinea pig
maximisat
ion test
guinea pig
Germ cell mutagenicity:
Hazardous components
CAS-No.
Result
Type of study /
Route of
administration
Metabolic
activation /
Exposure time
Species
Method
Propan-2-ol
67-63-0
negative with
metabolic
activation
mammalian cell
gene mutation assay
with and without
OECD Guideline 476 (In vitro
Mammalian Cell Gene
Mutation Test)
Propan-2-ol
67-63-0
negative
intraperitoneal
mouse
OECD Guideline 474
(Mammalian Erythrocyte
Micronucleus Test)
Adipic acid
124-04-9
negative
bacterial reverse
mutation assay (e.g
Ames test)
with and without
Carcinogenicity:
Hazardous components
CAS-No.
Result
Species
Sex
Exposure
timeFrequenc
y of treatment
Route of
application
Method
Propan-2-ol
67-63-0
rat
male/female
104 w
6 h/d, 5 d/w
inhalation:
vapour
OECD Guideline 451
(Carcinogenicity Studies)